During the past decade, Novo Cellular Medicine Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Novo Cellular Medicine Institute" are "Multiple Sclerosis, Relapsing-Remitting" (2 trials). Many other conditions were trialed in "Novo Cellular Medicine Institute" in a lesser frequency.

Most popular intervention types in "Novo Cellular Medicine Institute" are "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Liberation therapy" (2 trials), "Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells" (1 trials) and "Autologous Bone Marrow-Derived Mononuclear Stem Cells" (1 trials). Other intervention names were less common.

The vast majority of trials in "Novo Cellular Medicine Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Novo Cellular Medicine Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Novo Cellular Medicine Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Novo Cellular Medicine Institute, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".